胸主动脉腔内修复术后结局的性别差异:系统综述与Meta分析
本研究系统检索截至2023年6月10日的文献,纳入14项研究共17,374例胸主动脉腔内修复(TEVAR)患者(女性5026例、男性12,348例),采用随机效应模型合并分析。女性与男性在手术死亡率、卒中、脊髓缺血、急性肾损伤及住院时长上无显著差异,但女性总生存期较男性更差。
要点
- 女性TEVAR患者手术死亡率与男性无显著差异(RR 1.12,95%CI 0.90-1.40,P=.309)。
- 女性与男性在卒中、脊髓缺血、急性肾损伤及住院时长上均无显著差异。
- 女性TEVAR术后总生存期较男性更差(2年87.2% vs 89.8%,log-rank P=.001)。
核心结论
- 在TEVAR患者中,女性与手术死亡率或主要并发症风险增加无关,但女性术后总生存期较男性更低。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase、Web of Science和Cochrane Central数据库截至2023年6月10日发表的研究,最终纳入14项研究共17,374例患者(女性5026例,男性12,348例),采用随机效应模型合并数据,并重建个体患者数据生成性别特异性Kaplan-Meier曲线,研究注册于PROSPERO(CRD42023426069)。
主要发现
- 女性患者年龄更大、最大主动脉直径更小、吸烟和冠心病比例更低、贫血比例更高,术中更常使用髂动脉 conduit 并需要输血。
- 手术死亡率女性与男性无显著差异(RR 1.12,95%CI 0.90-1.40,P=.309)。
- 卒中女性与男性无显著差异(RR 1.14,95%CI 0.95-1.38,P=.165)。
- 脊髓缺血女性与男性无显著差异(RR 1.33,95%CI 0.83-2.14,P=.234)。
- 急性肾损伤女性与男性无显著差异(RR 0.78,95%CI 0.52-1.17,P=.228),住院时长亦无显著差异(标准化均数差 0.09,95%CI -0.03至0.20,P=.141)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: As it remains unclear whether there are sex-based differences in clinical outcomes after thoracic endovascular aortic repair (TEVAR), this meta-analysis aimed to evaluate differences in early outcomes and overall survival between female and male patients who underwent TEVAR. METHODS: The PubMed, Embase, Web of Science, and Cochrane Central databases were searched for eligible studies published through June 10, 2023, that reported sex-based differences in clinical outcomes after TEVAR. The primary outcome was operative mortality; second outcomes included stroke, spinal cord ischemia, acute kidney injury, hospital length of stay, and overall survival. Patient characteristics, operative data, and early outcomes were aggregated using the random-effects model, presenting pooled risk ratio (RR) or standardized mean difference along with their corresponding 95% confidence intervals (CIs). Overall survival was assessed by reconstructing individual patient data to generate sex-specific pooled Kaplan-Meier curves. This study was registered in PROSPERO (CRD42023426069). RESULTS: Of the 1785 studies retrieved, 14 studies met all eligibility criteria, encompassing a total of 17,374 patients, comprising 5026 female and 12,348 male patients. Female patients were older, had a smaller maximum aortic diameter, had lower rates of smoking and coronary artery disease, and had higher rates of anemia. Intraoperatively, female patients were more likely to use iliac conduits and require blood transfusions. There were no sex-based differences in operative mortality (RR: 1.12, 95% CI: 0.90-1.40; P = .309), stroke (RR: 1.14, 95% CI: 0.95-1.38; P = .165), spinal cord ischemia (RR: 1.33, 95% CI: 0.83-2.14; P = .234), acute kidney injury (RR: 0.78, 95% CI: 0.52-1.17; P = .228), and hospital length of stay (standardized mean difference: 0.09, 95% CI: -0.03 to 0.20; P = .141). Pooled Kaplan-Meier estimates showed a worse overall survival in female patients compared with male patients (87.2% vs 89.8% at 2 years, log-rank P = .001). CONCLUSIONS: Among patients treated by TEVAR, female sex was not associated with increased risk of operative mortality or major morbidity. However, female patients exhibited a lower overall survival after TEVAR compared with male patients.
引用
- Zhang Y, Zhang Y, Wang Y, et al. Sex-based outcomes after thoracic endovascular aortic repair: A systematic review and meta-analysis. J Vasc Surg. 2024. PMID: 38621637. doi:10.1016/j.jvs.2024.04.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。